Dr. Hildi Hagedorn is a Professor of Psychiatry at the University of Minnesota School of Medicine and Principal Investigator at the VA Center for Care Delivery and Outcomes Research. She is a nationally recognized expert in implementation science with a focus on implementation of evidence-based treatments for substance use disorders.

Dr. Margo Hurlocker is an Assistant Professor of Psychology at the University of New Mexico. Dr. Hurlocker’s research has focused on the prevention and treatment of substance use disorder comorbidity, and she has recently been awarded a K23 from the National Institute on Drug Abuse to improve addiction treatment services with Implementation Science.

Dr. Robert Coulter is an Assistant Professor in the Department of Behavioral and Community Health Sciences and Pediatrics and Clinical & Translational Science at the University of Pittsburgh. His research examines and seeks to address substance use and violence inequities for sexual and gender minority youth (SGMY; e.g., adolescents who identify as lesbian, gay, bisexual, transgender, queer [LGBTQ+]).

Dr. Angela Haeny is an Assistant Professor of Psychiatry and leads the Racial Equity and Addiction Lab (REAL) at Yale School of Medicine. She is a licensed Clinical Psychologist with specialty in substance use disorders. Her research investigates effective alcohol and drug treatments among individuals underrepresented in substance use research with a focus on Black adults. This work is funded by a 5-year career development award from the National Institute on Alcohol Abuse and Alcoholism.

Dr. Katie Witkiewitz is a Distinguished Professor of Psychology and the Director of the Center on Alcohol, Substance use, And Addictions at the University of New Mexico. Her research examines treatment of substance use disorder, with an emphasis on reducing human suffering, harm reduction, mechanisms of behavior change, precision medicine, and supporting recovery. Dr. Witkiewitz is also a licensed clinical psychologist and has worked extensively on the development, evaluation, and implementation of mindfulness-based treatments for substance use disorder.

Dr. Samuel Meisel is a postdoctoral fellow at Bradley Hospital and Brown University’s Center for Alcohol and Addiction Studies. His research seeks to (1) identify the developmental pathways leading adolescents to initiate and escalate their substance use and (2) leverage developmental science and mechanism of behavior change research to develop, refine, and scale adolescent substance use treatments.

Stephan A. Maisto, PhD, ABPP is a Professor of Psychology at Syracuse University. Dr. Maisto has been involved in clinical practice, research, and training on the assessment and treatment of substance use disorders, including MOBCs, for the past 35 years.

David "Ikela" Moniz-Lewis, M.S. is a clinical psychology doctoral student at the University of New Mexico and a National Institute on Alcohol Abuse and Alcoholism T32 Predoctoral Fellow. His clinical and research interests center on the mechanisms underlying the efficacy of mindfulness and acceptance-based treatments for alcohol and other substance use disorders, particularly among those with marginalized backgrounds.

Dr. Joseph Glass is an Associate Investigator at Kaiser Permanente – Washington Health Research Institute. Dr. Glass’ research has focused on delivery and implementation of evidence-based alcohol and other drug interventions within health and mental health settings.

Dr. Brett Hagman is a Program Director of the Treatment, Health Services, and Recovery Branch at the National Institute on Alcohol Abuse and Alcoholism. Dr. Hagman manages the following grant portfolios in : 1) Mechanisms of Behavior Change; (MOBC) 2) Processes of Recovery; and 3) Research Methods and Statistics.